Anti-nuclear autoantibodies in the general German population: prevalence and lack of association with selected cardiovascular and metabolic disorders—findings of a multicenter population-based study

[1]  C. Yuan,et al.  The Prevalence of Antinuclear Antibodies in the General Population of China: A Cross-Sectional Study , 2014, Current therapeutic research, clinical and experimental.

[2]  R. Heidari,et al.  Rheumatoid factor, anti-nuclear antibody in ischemic heart disease: Acute versus chronic patients , 2014, ARYA atherosclerosis.

[3]  Olga Rosa Brito-Zurita,et al.  Seroprevalencia de anticuerpos antinucleares en donadores de sangre del valle del Yaqui , 2014 .

[4]  H. Becher,et al.  Comparing sampling strategies to recruit migrants for an epidemiological study. Results from a German feasibility study. , 2014, European journal of public health.

[5]  R. Fischer-Betz,et al.  Age-specific prevalence of diagnosed systemic lupus erythematosus in Germany 2002 and projection to 2030 , 2014, Lupus.

[6]  German National Cohort Consortium,et al.  The German National Cohort: aims, study design and organization , 2014, European Journal of Epidemiology.

[7]  A. Tincani,et al.  Automated tests of ANA immunofluorescence as throughput autoantibody detection technology: strengths and limitations , 2014, BMC Medicine.

[8]  Nicola Bizzaro,et al.  Automated antinuclear immunofluorescence antibody screening: a comparative study of six computer-aided diagnostic systems. , 2014, Autoimmunity reviews.

[9]  Torsten Witte,et al.  International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies , 2013, Annals of the rheumatic diseases.

[10]  M. Cusini,et al.  Automated interpretation of ANCA patterns - a new approach in the serology of ANCA-associated vasculitis , 2012, Arthritis Research & Therapy.

[11]  Giuseppe Lippi,et al.  A comparative study on the reliability of an automated system for the evaluation of cell-based indirect immunofluorescence. , 2012, Autoimmunity reviews.

[12]  E. Volkmann,et al.  Using the Antinuclear Antibody Test to Diagnose Rheumatic Diseases: When Does a Positive Test Warrant Further Investigation? , 2012, Southern medical journal.

[13]  L. See,et al.  Antinuclear antibody status and risk of death in children and adolescents , 2011, Scandinavian journal of rheumatology.

[14]  N. Olsen,et al.  Risk factors for ANA positivity in healthy persons , 2011, Arthritis Research & Therapy.

[15]  Rico Hiemann,et al.  Automated evaluation of autoantibodies on human epithelial-2 cells as an approach to standardize cell-based immunofluorescence tests , 2010, Arthritis research & therapy.

[16]  T. Therneau,et al.  Autoantibodies and the Risk of Cardiovascular Events , 2009, The Journal of Rheumatology.

[17]  M. Cardiel,et al.  Prevalence of Antinuclear Antibodies in 3 Groups of Healthy Individuals: Blood Donors, Hospital Personnel, and Relatives of Patients With Autoimmune Diseases , 2009, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

[18]  Torsten Witte,et al.  Autoantibody Detection Using Indirect Immunofluorescence on HEp‐2 Cells , 2009, Annals of the New York Academy of Sciences.

[19]  Rico Hiemann,et al.  Challenges of automated screening and differentiation of non-organ specific autoantibodies on HEp-2 cells. , 2009, Autoimmunity reviews.

[20]  Takeo Kato,et al.  Relationship between antinuclear antibody and microalbuminuria in the general population: the Takahata study , 2008, Clinical and Experimental Nephrology.

[21]  M. Gaubitz.  Epidemiology of connective tissue disorders. , 2006, Rheumatology.

[22]  C. Valeri,et al.  Autoantibodies in Type 1 diabetes. , 2005, Clinica chimica acta; international journal of clinical chemistry.

[23]  L. Hegedüs,et al.  High prevalence of autoantibodies among Danish centenarians , 2004, Clinical and experimental immunology.

[24]  Daniel W. Jones,et al.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. , 2003, Hypertension.

[25]  R Hal Scofield,et al.  Development of autoantibodies before the clinical onset of systemic lupus erythematosus. , 2003, The New England journal of medicine.

[26]  D. Grainger,et al.  High titres of serum antinuclear antibodies, mostly directed against nucleolar antigens, are associated with the presence of coronary atherosclerosis , 2002, Annals of the rheumatic diseases.

[27]  JohnF. Robinson,et al.  The antinuclear antibody test. , 1993, Postgraduate medicine.

[28]  Ricardo Serrano-Osuna,et al.  [Seroprevalence of antinuclear antibodies in blood donors in the Yaqui Valley]. , 2014, Cirugia y cirujanos.

[29]  New S Tudy.  The German National Cohort: aims, study design and organization , 2014 .

[30]  Wolfgang Ahrens,et al.  The German National Cohort: Aims, study des , 2014 .

[31]  E. Lazaro,et al.  Inverse Association Between Obesity and Antinuclear Antibodies in Women , 2008 .

[32]  Benjamin J. Epstein,et al.  Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure , 2007 .